An observational study goes where randomized clinical trials have not

JAMA - Journal of the American Medical Association

Volumn 313, Issue 11, 2015, Pages 1091-1092

  Frakt, Austin B ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Boston University Medical Campus   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; GLUCOSE; SULFONYLUREA; ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

CLINICAL DECISION MAKING; COMPARATIVE STUDY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HOSPITALIZATION; HUMAN; INSTRUMENTAL VARIABLE ANALYSIS; INTERPRETATION BIAS; MORTALITY; NOTE; OBSERVATIONAL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; CLINICAL PRACTICE; DIABETES MELLITUS, TYPE 2; FOLLOW UP; METHODOLOGY; STATISTICAL BIAS;

BIAS (EPIDEMIOLOGY); DIABETES MELLITUS, TYPE 2; FOLLOW-UP STUDIES; HUMANS; HYPOGLYCEMIC AGENTS; OBSERVATIONAL STUDY AS TOPIC; PHYSICIAN'S PRACTICE PATTERNS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES;

EID: 84925884091     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.0544     Document Type: Note

References (0)